Patient-derived tumour organoids: a bridge between cancer biology and personalised therapy

W Wu, X Li, S Yu - Acta Biomaterialia, 2022 - Elsevier
… for formulating personalised anticancer therapeutic regimens (… treatment, suggesting the
potential use of cancer organoids for … bladder cancer organoid biobanks showed that organoids

The applications and techniques of organoids in head and neck cancer therapy

H Qi, X Tan, W Zhang, Y Zhou, S Chen, D Zha… - Frontiers in …, 2023 - frontiersin.org
potential application of organoids in head and neck cancer … to provide a more reliable platform
for assessing drug response, … development of personalized therapeutic strategies based …

The organoid as reliable cancer modeling in personalized medicine, does applicable in precision medicine of head and neck squamous cell carcinoma?

A Farshbaf, M Lotfi, R Zare, N Mohtasham - The Pharmacogenomics …, 2023 - nature.com
… a platform for individualized medicine [4]. Although recent … of 3D organoids in cancer
therapy based on personalized … and endocrine therapy, which suggest the potential use of this …

Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification

R Millen, WWB De Kort, M Koomen, GJF van Son… - Med, 2023 - cell.com
… for patients with head and neck cancer (HNC), we measured the response of organoids
to either … Oral mucosal organoids as a potential platform for personalized cancer therapy. …

Oral organoids: progress and challenges

X Gao, Y Wu, L Liao, W Tian - Journal of dental research, 2021 - journals.sagepub.com
Oral organoids provide great models for in vitro and in vivo … to the development of personalized
medicine for the treatment of … as the potential cell source to construct oral organoids in the …

Organoids in translational oncology

M Tatullo, B Marrelli, C Benincasa, E Aiello… - Journal of Clinical …, 2020 - mdpi.com
… to understand their role in anticancer therapy. In this study, … and for targeted therapies: this
will be possible, as tumoroids … Oral cancers tumoroids are a smart platform for personalized

Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia

E Driehuis, N Oosterom, SG Heil, IB Muller, M Lin… - PLoS …, 2020 - journals.plos.org
… to study the potential of LV to reduce MTX-induced toxicity. … Antifolates in cancer therapy:
structure, activity and mechanisms … recapitulate disease and allow personalized drug screening. …

Development of patient derived organoids for cancer drug screening applications

G Baskar, T Palaniyandi, S Viswanathan… - Acta …, 2022 - Elsevier
… frequent cancer treatment techniques with more contemporary … The potential of organoids
to complement current model … potential value in personalised drugs and future prospects. …

[HTML][HTML] Unveiling the potential: Patient-derived organoids in cancer research and treatment

Z Wang - Oral Oncology Reports, 2024 - Elsevier
… effective personalized treatment strategies. As the field continues to advance, organoid
an increasingly prominent role in driving innovation and improving patient care in oncology. …

Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening

SY Choi, J Shim, D Gu, SY Kim, HJ Kim, DY Shin… - Oral Oncology, 2023 - Elsevier
… In oral cavity cancer, surgery is still the mainstay of cancer therapy. In contrast, RT with or
without … and TrypLE might potentially reduce cancer stem cell (CSC) survival, self-renewal, and …